Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Marco A. Velasco-Velázquez

Professor

National Autonomous University of Mexico

No Info

Research Interests

Explore related searches

Professors in Cell Biology

Articles (25)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Luis Cordova-Bahena

Researcher

National Autonomous University of Mexico

View details

Laura Cobos

PROFESSOR

National Autonomous University of Mexico

View details

Nohemí Salinas-Jazmín

Profesora de Carrera Titular "B" definitiva

National Autonomous University of Mexico

View details

Zhiqiang An

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Jose L Medina-Franco

Professor

National Autonomous University of Mexico

View details

Pablo Hernández Peralta

Professor

National Autonomous University of Mexico

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco A. Velasco-Velázquez

Research Interests

Explore related searches

Articles (25)

Daclatasvir, A Symmetric Drug for an Anti-Symmetric Target

Pseudouridine synthase 7 as a context-specific therapeutic target in cancer

Uso de supercómputo para el descubrimiento de fármacos: un caso de estudio sobre CK1ε

Non-Clinical Evaluation of the Anti-PD-1 Antibody UDIZ-007

Targeting the Barriers Driving Immune Exclusion

In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers

Identification of New CD36 Antagonists by Structure‐Based Virtual Screening

In Silico Identification of 2,4-Diaminopyrimidine-Based Compounds as Potential CK1ε Inhibitors

<i>In silico</i> characterization of the interaction of AKR1B1 with the deacetylase activation domain (DAD)

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

The Evolving Field of Tumor Immunopharmacology

The Regulatory Role of CTCF in IL6 Gene Transcription Assessed in Breast Cancer Cell Lines

Discovery and <i>in vitro</i> characterization of a human anti-CD36 scFv

The roles and perspectives of YY1 in immune central tolerance establishment

Neuroprotective Agents with Therapeutic Potential for COVID-19

Agave mapisaga aqueous extract shows in vitro and in vivo activity on murine prostate cancer cells

Role of CD36 in cancer progression, stemness, and targeting.

DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications.

Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein

High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma

The interplay between estrogen receptor beta and protein kinase C, a crucial collaboration for medulloblastoma cell proliferation and invasion

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening

Progesterone Receptor Together with PKCα Expression as Prognostic Factors for Astrocytomas Malignancy

In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates

Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?

Collaborators (6)

Luis Cordova-Bahena

Laura Cobos

Nohemí Salinas-Jazmín

Zhiqiang An

Jose L Medina-Franco

Pablo Hernández Peralta

Make your next move.